To generate engineered T cells with specific cytotoxicity for tumor cells, a wide variety of potential tumor targets are under consideration, such as mesothelin (MSLN), carcinoembryonic antigen (CEA), epidermal growth factor receptor, human epidermal growth factor receptor 2, and so on [22]. Here, ERBB2 is linked to neoplasm.